Tag: Cancer Care
-

AGAT Foundation Supports Cancer Care Through Priddis Classic
Raising Funds and Awareness for Cancer Care AGAT Laboratories has long integrated community support into its core operations. Built on 45 years of scientific testing and data-driven solutions, the company extends its commitment through the AGAT Foundation, the philanthropic arm dedicated to giving back to its communities. Under the leadership of Marissa Reckmann, CEO of…
-

Two Endowed Chairs Poised to Transform Cancer Care in London
Major Gift Fuels Long-Term Cancer Research at Western University Canada faces a sobering reality: almost half of the population is expected to receive a cancer diagnosis in their lifetime. In response, a groundbreaking $5 million donation from the late Archie and Irene Verspeeten, channeled through the London Health Sciences Foundation (LHSF) and matched by Western…
-

Raising Money and Awareness for Cancer Care: AGAT Foundation’s Drive for Hope and Priddis Greens Charity Classic
Raising Money and Awareness for Cancer Care: A Community-Driven Effort Raising money and awareness for cancer care is a mission that many communities rally around. At the heart of this effort in Canada is the AGAT Foundation, the philanthropic arm of AGAT Laboratories. For 45 years, AGAT Laboratories has delivered analytical testing and data-driven solutions…
-

AGAT Foundation: Raising Money and Awareness for Cancer Care
Overview: A Foundation Rooted in Community Service Raising money and awareness for cancer care is at the core of the AGAT Foundation, the philanthropic arm of AGAT Laboratories. For 45 years, AGAT Laboratories has delivered analytical laboratory testing and data-driven solutions across a wide range of sectors, from environmental consulting to life sciences. The Foundation…
-

Living with cancer in Ireland: how personalized treatment is changing outcomes
Growing a new approach: from one-size-fits-all to personalized cancer care In Ireland, the cancer landscape has shifted dramatically in the last decade. The story of Lydia Whelan, a 32-year-old diagnosed with stage 2 HER2+ breast cancer in 2024, reflects a broader national trend: treatments are becoming more tailored, more precise, and more hopeful for patients…
-

Living with cancer in Ireland: We’ve moved from a one-size-fits-all treatment
From uniform treatments to personalised cancer care In Ireland, the cancer treatment landscape has shifted dramatically over the last decade. Patients who once faced a one-size-fits-all approach now benefit from personalised strategies that target the biology of their disease. For Lydia Whelan, a 32-year-old diagnosed with stage 2 HER2+ breast cancer in 2024, this evolution…
-

Lessons from Denmark: Boosting NHS Cancer Survival Rates
Introduction The landscape of cancer treatment has evolved significantly over the past few decades, with various countries implementing strategies to improve patient outcomes. One notable transformation occurred in Denmark, where concerted efforts led to a remarkable increase in cancer survival rates. This article explores what the NHS can learn from Denmark’s experience in mitigating cancer…


